SEC Form 4 · accession 0001179110-16-024356
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul W.D. Chapman
Officer — Chief Operating Officer
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 8:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2016 | P | 3,100 | $7.37 | A | 3,100 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 reflects the purchase of 3,100 shares by Mr. Chapman in the market.